News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Affymetrix (Santa Clara, California) (AFFX) Completes Strategic Licensing Agreement with Genisphere for Proprietary MicroRNA Reagents



11/17/2011 7:50:11 AM

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix®, Inc. (NASDAQ:AFFX) announced today at the Association of Molecular Pathology (AMP) conference that they have entered into an exclusive agreement with Genisphere®, LLC, to offer the company’s proprietary FlashTag™ Biotin HSR Reagents designed for Affymetrix. The miRNA reagents provide streamlined, high-fidelity target preparation methods yielding high quality data and unmatched reproducibility when used with the Affymetrix GeneChip® Arrays.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES